One-year observational study of palivizumab prophylaxis on infants at risk for respiratory syncytial virus infection in Latin America

Journal Title: Jornal de Pediatria - Year 2017, Vol 93, Issue 5

Abstract

Objective This study aims to describe real world palivizumab use and effectiveness in high-risk Latin American infants and young children. Method Prospective, multicenter observational study with infants at risk for severe RSV infection who received palivizumab according to routine clinical practice. Subjects were followed for one year with monthly visits after the first dose of palivizumab. An infant was considered adherent if receiving all the expected injections or five or fewer injections within appropriate inter-dose intervals. Annual incidence rates and risk factors of lower respiratory tract infection (LRTI) hospitalization were determined through Poisson regression models (α=0.05). Results The study enrolled 458 children from seven countries in Latin America, from February 2011 to September 2012. The majority (98%) were born <36 weeks gestation. Overall, patients received 83.7% of their expected injections and 86.7% completed one year of follow-up. Of the 61 LRTI hospitalizations, 12 episodes were due to RSV infection. The RSV-associated hospitalization rate was 2.9 per 100 patient-years. Bronchopulmonary dysplasia was identified as an independent risk factor for LRTI hospitalization. A total of 1165 adverse events were recorded during one year of follow-up. One hundred and two patients (22.3%) had a total of 135 serious adverse events, but no events were considered to be related to palivizumab. Conclusions The rate of RSV hospitalization in high-risk infants in Latin America was low and aligned with those observed in randomized control trials and observational studies. Palivizumab prophylaxis appeared effective and had a good safety profile in this population.

Authors and Affiliations

Gabriela Bugarin

Keywords

Related Articles

Psychopathology, quality of life, and related factors in children with celiac disease

Objective This study aimed to survey children with celiac disease (CD) for psychiatric disorders, determine the possible factors that predict psychopathology, and analyze health-related quality of life and possible facto...

Association of hypertriglyceridemic-waist phenotype with liver enzymes and cardiometabolic risk factors in adolescents: the CASPIAN-III study

Objective This study aims to investigate the role of metabolic syndrome (MetS) and the hypertriglyceridemic-waist (HW) phenotype in determining cardiometabolic risk factors and elevated liver enzymes in a national sample...

Management protocols for status epilepticus in the pediatric emergency room: systematic review article

Objective This systematic review of national or regional guidelines published in English aimed to better understand variance in pre-hospital and emergency department treatment of status epilepticus. Sources Systematic s...

The longitudinal relationship between motor competence and measures of fatness and fitness from childhood into adolescence

Objectives To examine longitudinal (seven years) relationships among cardiorespiratory fitness (VO2peak), body fatness, and motor competence. Method Data were collected as part of the Copenhagen School Child Interventio...

Maple syrup urine disease in Brazil: a panorama of the last two decades

Objective To characterize a sample of Brazilian patients with maple syrup urine disease (MSUD) diagnosed between 1992 and 2011. Methods In this retrospective study, patients were identified through a national reference...

Download PDF file
  • EP ID EP503536
  • DOI 10.1016/j.jped.2016.11.006
  • Views 42
  • Downloads 0

How To Cite

Gabriela Bugarin (2017). One-year observational study of palivizumab prophylaxis on infants at risk for respiratory syncytial virus infection in Latin America. Jornal de Pediatria, 93(5), 467-474. https://europub.co.uk/articles/-A-503536